The Japanese health ministry said on Saturday that two men had died after each received two shots of Moderna Inc.'s Covid-19 vaccine, local media reported.
According to the ministry, the two men aged 30 and 38 died within days of receiving the second injection on August 22 and 15, respectively, and no foreign matter was found in either of the vials of vaccine used on the two men, the Xinhua news agency reported.
It remains unknown whether there is a causal relationship between the vaccination and their deaths, the ministry said, adding that neither of them had an underlying medical condition or a history of allergic reactions.
Japan's health ministry said Thursday that foreign substances have been found in 39 unused vials at eight vaccination sites in five prefectures. The same day, about 1.63 million doses that came from the same production line of a Spanish factory were suspended to use as a precaution.
However, more than 500,000 shots have already been administered from the potentially contaminated batches, said Taro Kono, the Japanese minister in charge of the vaccination effort.
Although the foreign substances had been confirmed since August 16, the Japanese drugmaker Takeda Pharmaceutical Co., which is in charge of the sale and distribution of the Moderna vaccine in Japan, waited until Wednesday to report the problem to the ministry.
Moderna and Takeda said in a joint statement Saturday that they were working with the health ministry to investigate the two deaths.
The two companies said that at this time, they did not find any evidence that these deaths were caused by the Moderna Covid-19 vaccine.
--IANS
int/rs
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)